Abstract:Increasing evidence has indicated that modulation of epigenetic mechanisms, especially methylation and long-non-coding RNA (lncRNA) regulation, plays a pivotal role in the process of atherosclerosis; however, few studies focused on revealing the epigenetic-related subgroups during atherosclerotic progression using unsupervised clustering analysis. Hence, we aimed to identify the epigenetics-related differentially expressed genes associated with atherosclerosis subtypes and characterize their clinical utility in atherosclerosis. Eighty samples with expression data (GSE40231) and 49 samples with methylation data (GSE46394) from a large artery plaque were downloaded from the GEO database, and aberrantly methylated–differentially expressed (AMDE) genes were identified based on the relationship between methylation and expression. Furthermore, we conducted weighted correlation network analysis (WGCNA) and co-expression analysis to identify the core AMDE genes strongly involved in atherosclerosis. K-means clustering was used to characterize two subtypes of atherosclerosis in GSE40231, and then 29 samples were recognized as validation dataset (GSE28829). In a blood sample cohort (GSE90074), chi-square test and logistic analysis were performed to explore the clinical implication of the K-means clusters. Furthermore, significance analysis of microarrays and prediction analysis of microarrays (PAM) were applied to identify the signature AMDE genes. Moreover, the classification performance of signature AMDE gene-based classifier from PAM was validated in another blood sample cohort (GSE34822). A total of 1,569 AMDE mRNAs and eight AMDE long non-coding RNAs (lncRNAs) were identified by differential analysis. Through the WGCNA and co-expression analysis, 32 AMDE mRNAs and seven AMDE lncRNAs were identified as the core genes involved in atherosclerosis development. Functional analysis revealed that AMDE genes were strongly related to inflammation and axon guidance. In the clinical analysis, the atherosclerotic subtypes were associated with the severity of coronary artery disease and risk of adverse events. Eight genes, including PARP15 , SERGEF , PDGFD , MRPL45 , UBR1 , STAU1 , WIZ , and LSM4 , were selected as the signature AMDE genes that most significantly differentiated between atherosclerotic subtypes. Ultimately, the area under the curve of signature AMDE gene-based classifier for atherosclerotic subtypes was 0.858 and 0.812 in GSE90074 and GSE34822, respectively. This study identified the AMDE genes (lncRNAs and mRNAs) that could be implemented in clinical clustering to recognize high-risk atherosclerotic patients.

Bioinformatics Identification of Aberrantly Methylated Differentially Expressed Genes Associated with Arteriosclerosis by Integrative Analysis of Gene Expression and DNA Methylation Datasets

Aberrantly Methylated-Differentially Expressed Genes Identify Novel Atherosclerosis Risk Subtypes

Identification of Key Genes in Atherosclerosis by Combined DNA Methylation and miRNA Expression Analyses

Bioinformatic analysis and experimental validation identified DNA methylation–Related biomarkers and immune-cell infiltration of atherosclerosis

Integrated Analysis of Gene Expression and Methylation Data to Identify Potential Biomarkers Related to Atherosclerosis Onset.

Integrated Investigation of DNA Methylation, Gene Expression and Immune Cell Population Revealed Immune Cell Infiltration Associated with Atherosclerotic Plaque Formation

DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A2 in human vulnerable atherosclerotic plaque

Identification of Potential Biomarkers for CAD Using Integrated Expression and Methylation Data

473-P: Identification of Novel Genes Participating in Diabetic Macrovascular Complications by DNA Methylation Modulation

Identification of Key Candidate Biomarkers and Pathways in Atherosclerosis

Identification of potential biomarkers for CAD using integration with expression and methylation data and validation by case-control study

miR-520e and its promoter region DNA methylation as potential biomarkers in atherosclerosis

Identification of key genes and pathways in atherosclerosis using integrated bioinformatics analysis

The relationship among ABCA1 DNA methylation and atherosclerosis and blood lipids

Integrated DNA methylation and gene expression analysis in the pathogenesis of coronary artery disease

Epigenome-wide DNA methylation study of whole blood in patients with sporadic amyotrophic lateral sclerosis

The Identification of Candidate Biomarkers and Pathways in Atherosclerosis by Integrated Bioinformatics Analysis

Identification and preliminary validation of differently expressed genes as candidate biomarkers associated with atherosclerosis

The Comprehensive Effects of Hyperlipidemia and Hyperhomocysteinemia on Pathogenesis of Atherosclerosis and Dna Hypomethylation in Apoe(-/-) Mice

Role of DNA Methylation in Ischemic-Hypoxic Endothelial Cells and its Clinical Implications in AMI Patients

Methylation and transcriptomic expression profiles of HUVEC in the oxygen and glucose deprivation model and its clinical implications in AMI patients